DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 161 filers reported holding DEPOMED INC in Q1 2018. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $273,000 | +1.1% | 40,975 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $270,000 | -16.1% | 40,975 | +2.5% | 0.00% | 0.0% |
| Q4 2017 | $322,000 | +39.4% | 39,975 | -0.0% | 0.00% | 0.0% |
| Q3 2017 | $231,000 | -46.2% | 39,977 | +0.0% | 0.00% | -50.0% |
| Q2 2017 | $429,000 | -15.0% | 39,975 | -0.7% | 0.00% | -33.3% |
| Q1 2017 | $505,000 | -30.1% | 40,245 | +0.5% | 0.00% | -25.0% |
| Q4 2016 | $722,000 | -27.9% | 40,060 | -0.2% | 0.00% | -33.3% |
| Q3 2016 | $1,002,000 | +27.5% | 40,131 | +0.1% | 0.01% | 0.0% |
| Q2 2016 | $786,000 | +12.1% | 40,075 | -20.4% | 0.01% | +20.0% |
| Q1 2016 | $701,000 | -5.5% | 50,325 | +23.0% | 0.01% | -16.7% |
| Q4 2015 | $742,000 | -7.6% | 40,925 | -3.9% | 0.01% | -14.3% |
| Q3 2015 | $803,000 | -16.0% | 42,575 | -4.4% | 0.01% | -22.2% |
| Q2 2015 | $956,000 | +7866.7% | 44,525 | +7995.5% | 0.01% | – |
| Q1 2015 | $12,000 | +200.0% | 550 | +10.0% | 0.00% | – |
| Q3 2013 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
| Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
| Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
| PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
| HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
| ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
| Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
| Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
| TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |